Absci (ABSI) Depreciation & Amortization (CF) (2020 - 2026)

Absci (ABSI) posted Depreciation & Amortization (CF) of $2.7 million for Q1 2026, down 3.54% sequentially from $2.8 million in Q4 2025, and down 11.2% YoY from $3.1 million in Q1 2025.

Absci (ABSI) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Absci has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $2.7 million in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 11.2% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.4 million (down 12.63% YoY) and the FY2025 annual result came in at $11.7 million, down 12.3% from the prior year.
  • Depreciation & Amortization (CF) retreated to $2.7 million in Q1 2026 per ABSI's latest filing, from $2.8 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $3.6 million in Q4 2022 and troughed at $2.7 million in Q1 2026.
  • A 5-year average of $3.2 million and a median of $3.4 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 510.5% in 2022, then dropped 15.29% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $3.6 million in 2022, then slipped by 2.84% to $3.5 million in 2023, then dropped by 7.18% to $3.2 million in 2024, then decreased by 12.55% to $2.8 million in 2025, then fell by 3.54% to $2.7 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $2.7 million, $2.8 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.10 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 40.52 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 3.18 Mn
10 Absci 1.58 Bn 1.37 Bn - 2.70 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.70 Mn
Jun 30, 2026 2.70 Mn
Mar 31, 2026 2.73 Mn
Mar 31, 2026 2.73 Mn
Dec 31, 2025 2.83 Mn
Dec 31, 2025 2.83 Mn
Sep 30, 2025 2.84 Mn
Sep 30, 2025 2.84 Mn
Jun 30, 2025 3.00 Mn
Jun 30, 2025 3.00 Mn
Mar 31, 2025 3.07 Mn
Mar 31, 2025 3.07 Mn
Dec 31, 2024 3.23 Mn
Dec 31, 2024 3.23 Mn
Sep 30, 2024 3.36 Mn
Sep 30, 2024 3.36 Mn
Jun 30, 2024 3.38 Mn
Jun 30, 2024 3.38 Mn
Mar 31, 2024 3.42 Mn
Mar 31, 2024 3.42 Mn